Community Practice Connections™: Chronic Kidney Disease and T2D: Evolving Strategies in Diagnosis and Treatment

Target Audience
This educational activity is directed toward all attendees of the American Diabetes Association’s Virtual 81st Scientific Sessions: primary care physicians, diabetologists, endocrinologists, cardiologists, nephrologists, certified diabetes educators, nurse practitioners, physician assistants, and other health care practitioners who treat patients with CKD.

Activity Overview
Diabetic kidney disease is a disease multiplier that increases the risk of stroke, cardiac, and vascular disease, yet almost 50% of patients with diabetes are not routinely screened to allow for diagnosis and appropriate treatment. Newer classes of glucose-lowering agents have demonstrated both renal and cardiac benefits for patients with diabetes, and the first class of agents for treatment of chronic kidney disease (CKD) has recently been approved.

This Community Practice Connection™ program provides an in-depth review of some of the key highlights from the virtual symposium at the American Diabetes Association annual meeting held June 27, 2021. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with diabetes and putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Learning Objectives
Upon successful completion of this activity, you should be better prepared to:

List recommended diagnostic practices for CKD in patients with T2D
Elaborate on the relationship between CKD and cardiovascular and renal outcomes
Discuss the complex pathophysiology of CKD and emerging approaches to intervene in disease progression
Evaluate the efficacy and safety of nonsteroidal mineralocorticoid receptor antagonists and other therapies under investigation for the treatment of patients with CKD